Arriva Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 21

Loading Chart...

3 inventors (with patents filed for the assignee):

Philip J Barr (4 out of 67 patents)

Helen L Gibson (4 out of 9 patents)

Philip A Pemberton (2 out of 3 patents)

4. Timothy Kreiger (1 patent)

5. Ian C Bathurst (14 patents)

6. Ken Kabingue (0 patent)

7. Virginia Mosher (0 patent)

8. Harish Kumar (0 patent)

9. Manzer J Durrani (0 patent)

4 patents: Sort by Forward Citations

1. 7914771 - Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor (2011-03-29),

2. 7892825 - Method of protein production in yeast (2011-02-22),

3. 7419801 - Methods of protein production in yeast (2008-09-02),

4. 7247704 - Multifunctional protease inhibitors and their use in treatment of disease (2007-07-24),

Company Overview

Arriva Pharmaceuticals, Inc. is a leading pharmaceutical company dedicated to developing innovative therapies for various medical conditions. With a focus on research and development, Arriva Pharmaceuticals aims to improve patient outcomes and quality of life. The company offers a wide range of products and services to meet the healthcare needs of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#54 in Alameda, CA

#14,086 in California

#60,778 in US

Alameda, CA, United States of America

Arriva Pharmaceuticals, Inc.

Forward Citations = 21

3 inventors:

Philip J Barr (4 out of 67 patents)

Helen L Gibson (4 out of 9 patents)

Philip A Pemberton (2 out of 3 patents)

4. Timothy Kreiger (1 patent)

5. Ian C Bathurst (14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arriva Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/arriva-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]